These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2876654)

  • 21. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why was early therapeutic research on psychedelic drugs abandoned?
    Hall W
    Psychol Med; 2022 Jan; 52(1):26-31. PubMed ID: 34670633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.
    Fogg C; Michaels TI; de la Salle S; Jahn ZW; Williams MT
    Exp Clin Psychopharmacol; 2021 Oct; 29(5):539-554. PubMed ID: 34096755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The future of hallucination research: Can hallucinogens and psychedelic drugs teach us anything?
    Waters F
    Psychiatry Res; 2023 Jan; 319():114968. PubMed ID: 36462291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use.
    Liester MB; Grob CS; Bravo GL; Walsh RN
    J Nerv Ment Dis; 1992 Jun; 180(6):345-52; discussion 353-4. PubMed ID: 1350613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.
    Smith DE; Raswyck GE; Davidson LD
    J Psychoactive Drugs; 2014; 46(1):3-10. PubMed ID: 24830180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential dangers of using MDMA for psychotherapy.
    Parrott AC
    J Psychoactive Drugs; 2014; 46(1):37-43. PubMed ID: 24830184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs.
    Grob CS; Bravo GL; Walsh RN; Liester MB
    J Nerv Ment Dis; 1992 Jun; 180(6):355-6. PubMed ID: 1350614
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hallucinogens, a Troyan horse?].
    van Praag HM
    Ned Tijdschr Geneeskd; 1968 Nov; 112(44):1985-9. PubMed ID: 5687139
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can psychedelics have a role in psychiatry once again?
    Sessa B
    Br J Psychiatry; 2005 Jun; 186():457-8. PubMed ID: 15928353
    [No Abstract]   [Full Text] [Related]  

  • 32. The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review.
    Parrott AC
    Psychopharmacology (Berl); 2007 Apr; 191(2):181-93. PubMed ID: 17297639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dangerous method? Psychedelic therapy at Modum Bad, Norway, 1961-76.
    Johnstad PG
    Hist Psychiatry; 2020 Jun; 31(2):217-226. PubMed ID: 31928087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A method of conducting therapeutic sessions with MDMA.
    Greer GR; Tolbert R
    J Psychoactive Drugs; 1998; 30(4):371-9. PubMed ID: 9924843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The uses and abuses of L.S.D. and other hallucinogenic drugs.
    Barnes DT
    Aust N Z J Psychiatry; 1970 Dec; 4(4):170-3. PubMed ID: 5286778
    [No Abstract]   [Full Text] [Related]  

  • 36. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
    Bouso JC; Doblin R; Farré M; Alcázar MA; Gómez-Jarabo G
    J Psychoactive Drugs; 2008 Sep; 40(3):225-36. PubMed ID: 19004414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meetings at the edge with Adam: a man for all seasons?
    Wolfson PE
    J Psychoactive Drugs; 1986; 18(4):329-33. PubMed ID: 2880947
    [No Abstract]   [Full Text] [Related]  

  • 39. Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects.
    Strassman RJ
    J Nerv Ment Dis; 1995 Mar; 183(3):127-38. PubMed ID: 7891058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of alcoholism using psychedelic drugs: a review of the program of research.
    Mangini M
    J Psychoactive Drugs; 1998; 30(4):381-418. PubMed ID: 9924844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.